- Home
- PRMB vs MEDP Comparison
PRMB vs MEDP Comparison
Compare PRMB & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRMB
- MEDP
- Stock Information
- Founded
- PRMB 1955
- MEDP 1992
- Country
- PRMB United States
- MEDP United States
- Employees
- PRMB N/A
- MEDP N/A
- Industry
- PRMB
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PRMB
- MEDP Health Care
- Exchange
- PRMB Nasdaq
- MEDP Nasdaq
- Market Cap
- PRMB 11.0B
- MEDP 11.7B
- IPO Year
- PRMB N/A
- MEDP 2016
- Fundamental
- Price
- PRMB $31.07
- MEDP $346.47
- Analyst Decision
- PRMB
- MEDP Buy
- Analyst Count
- PRMB 0
- MEDP 10
- Target Price
- PRMB N/A
- MEDP $389.00
- AVG Volume (30 Days)
- PRMB 2.1M
- MEDP 277.5K
- Earning Date
- PRMB 01-01-0001
- MEDP 02-10-2025
- Dividend Yield
- PRMB 3.80%
- MEDP N/A
- EPS Growth
- PRMB N/A
- MEDP 33.84
- EPS
- PRMB 140.65
- MEDP 11.42
- Revenue
- PRMB $4,841,300,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- PRMB N/A
- MEDP $14.01
- Revenue Next Year
- PRMB N/A
- MEDP $5.86
- P/E Ratio
- PRMB $0.22
- MEDP $30.54
- Revenue Growth
- PRMB 9.01
- MEDP 16.24
- 52 Week Low
- PRMB $14.06
- MEDP $277.72
- 52 Week High
- PRMB $32.25
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- PRMB N/A
- MEDP 52.65
- Support Level
- PRMB N/A
- MEDP $340.06
- Resistance Level
- PRMB N/A
- MEDP $359.49
- Average True Range (ATR)
- PRMB 0.00
- MEDP 9.00
- MACD
- PRMB 0.00
- MEDP 0.55
- Stochastic Oscillator
- PRMB 0.00
- MEDP 43.31
About PRMB Primo Brands Corporation Class A Common Stock
Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and innovative brand packaging portfolio, which includes recycled plastic, aluminum, and glass.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.